2020 End of Year Summary

Research Triangle Park, North Carolina, December 31st, 2020 – Redbud Labs (“Redbud”) closed out an active year for new product development. Early in 2020, Redbud Labs announced its ISO certification and an expansion of its product lines. Responding to the COVID-19 outbreak, Redbud adjusted its operating plans and began new internal R&D projects. The company’s major developments in 2020 included:

REDBUD LABS Expands STR and MXR chip offerings with STR™BeadPak and MXR™DryPak

REDBUD LABS Earns ISO 9001 and ISO 45001 Certifications

COVID-19 induced Redbud Labs to shift our operating practices and share our perspective on the future of molecular diagnostics. We also kicked off new system development projects, which we will begin sharing publicly through conferences and other events in 2021.

In a challenging year for so many around the world, we extend our heartfelt thanks to all the front-line health professionals; essential workers in education, childcare, retail, and logistics; public servants, especially those in health and safety; and biotechnology professionals who in record time delivered diagnostics, therapies, and—remarkably—vaccines. We have never been prouder to be a member of this industry, and can’t wait to share what we’ve been working on.